Form 4: Curis Inc. Director Borgman Acquires Stock Options
Insider Transaction Report
Curis Inc. Director Anne Elizabeth Borgman acquired 6,800 stock options with an exercise price of $5.29, vesting fully on July 7, 2027.
Summary
- Anne Elizabeth Borgman, a Director at Curis Inc., was granted 6,800 non-qualified stock options on July 7, 2026.
- The exercise price for these options is $5.29 per share.
- The options are set to vest 100% on July 7, 2027.
- These options are exercisable until July 6, 2036.
- The filing also includes a Power of Attorney document appointing individuals to act on behalf of Ms. Borgman for SEC filings.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard stock option grant to a director, which is a common compensation practice and does not inherently signal positive or negative news about the company's performance.
Positives
- Director acquisition of stock options can signal confidence in the company's future prospects.
- The grant of options provides potential upside for the director tied to the company's stock performance.
Risks
- The value of the stock options is contingent on the future performance of Curis Inc.'s stock price exceeding the exercise price of $5.29.
- There is a vesting period of one year, meaning the options cannot be exercised until July 7, 2027.
Future Outlook
The stock options granted have a future vesting date and a long-term expiration date, indicating a potential future financial benefit for the director if the company's stock performs well.
Industry Context
StockSavvy.ai notes that insider option grants are common in the biotechnology and pharmaceutical sectors, often used as a long-term incentive to align management and director interests with shareholder value.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | Anne Elizabeth Borgman has executed a Power of Attorney, appointing specific individuals to act on her behalf for executing and filing Section 16 reports (Forms 3, 4, and 5) with the SEC. | 04/24/2026 | Ensures compliance with SEC reporting requirements for insider transactions, even in the absence of the reporting person. |
Stakeholder Impact
- Shareholders: The grant of options to a director is a standard compensation practice. Its impact on shareholders depends on the company's future stock performance and the alignment of director incentives with shareholder interests.
- Management/Directors: Anne Elizabeth Borgman has a potential financial incentive tied to the company's stock performance.
- Employees: This filing does not directly impact employees, but it is part of the overall compensation structure for key personnel.
Next Steps
- The stock options will vest on July 7, 2027.
- The options can be exercised anytime between July 7, 2027, and July 6, 2036.
Key Dates
| Date | Description |
|---|---|
| 04/24/2026 | Date of Power of Attorney document. |
| 07/07/2026 | Transaction Date for stock option grant. |
| 07/07/2027 | Vesting date for 100% of the underlying shares. |
| 07/06/2036 | Expiration date of the stock options. |
| 07/09/2026 | Date of signature on the Form 4 filing. |
Keywords
Curis Inc., CRIS, Form 4, Stock Options, Insider Trading, Director, Beneficial Ownership, SEC Filing, Securities Exchange Act
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.